Primary Anaplastic Lymphoma Kinase-Negative Breast Anaplastic Large Cell Lymphoma Without Breast Implant Association: A Case Report.

Int J Surg PatholMay 21, 2026 (epub)

Mine Ozsen, Kazım Senol, Ulviye Yalcınkaya et al.

✦ AI-curated · Sources linked

Case in brief

A 26-year-old woman with no history of breast implantation presented with right breast pain and a palpable mass persisting for 3 months. Imaging showed a complex cystic lesion suspicious for malignancy. Core biopsy revealed diffuse infiltration by large atypical, pleomorphic cells with increased mitotic activity. The cells were strongly CD30-positive, focally positive for epithelial membrane antigen, and negative for ALK, keratin AE1/AE3, CD20, and EBV. After breast-conserving surgery, the lesion was diagnosed as primary ALK-negative anaplastic large cell lymphoma.

What made this case unusual

The lymphoma occurred in a young patient without breast implants, despite the usual association of breast anaplastic large cell lymphoma with implants.

Diagnostic / clinical pearl

A complex cystic breast mass can represent ALK-negative anaplastic large cell lymphoma; diagnosis depends on histopathological assessment and immunophenotyping, including CD30 and ALK.

Source

Published in Int J Surg Pathol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pathology (Anatomic & Clinical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.